Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonny Peter

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
BMC Infectious Diseases|July 10, 2015
Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testingJonny Peter, Grant Theron, Duncan Chanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Grant Theron, Rouxjeane Venter, Greg Calligaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2011
The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patientsGrant Theron, Lancelot Pinto, Jonny Peter, et al.
Scientific Reports|April 14, 2025
Integrated renin angiotensin system dysregulation and immune profiles predict COVID-19 disease severity in a South African cohortTalitha Müller, Sonwabile Dzanibe, Cascia Day, et al.
Allergy|October 22, 2025
Unifying Global Drug Allergy: Clarifying Concepts and Defining Low-Risk Penicillin AllergyPhilip H Li, Vito Sabato, David A Khan, et al.
The New England Journal of Medicine|June 2, 2021
Thromboembolic Events in the South African Ad26.COV2.S Vaccine StudySimbarashe Takuva, Azwidhwi Takalani, Nigel Garrett, et al.
JAAD International|November 11, 2024
Patients with severe cutaneous adverse drug reactions have extremely high hair cortisol concentrations that do not correlate with the presence of depressionEddy M Zitha, Ogheneochuko U Oputu, Sthomo Mevana, et al.
Plos Pathogens|September 19, 2025
The association of class II HLA alleles with tuberculosis-associated immune reconstitution inflammatory syndromePhuti Choshi, Sarah Pedretti, Tafadzwa Chimbetete, et al.
Plos One|April 25, 2015
High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisElize Pietersen, Jonny Peter, Elizabeth Streicher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis SettingsRose Selim, Bukiwe Thwala, Mireille Porter, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
BMC Infectious Diseases|July 10, 2015
Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testingJonny Peter, Grant Theron, Duncan Chanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2016
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Grant Theron, Rouxjeane Venter, Greg Calligaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2011
The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patientsGrant Theron, Lancelot Pinto, Jonny Peter, et al.
Scientific Reports|April 14, 2025
Integrated renin angiotensin system dysregulation and immune profiles predict COVID-19 disease severity in a South African cohortTalitha Müller, Sonwabile Dzanibe, Cascia Day, et al.
Allergy|October 22, 2025
Unifying Global Drug Allergy: Clarifying Concepts and Defining Low-Risk Penicillin AllergyPhilip H Li, Vito Sabato, David A Khan, et al.
The New England Journal of Medicine|June 2, 2021
Thromboembolic Events in the South African Ad26.COV2.S Vaccine StudySimbarashe Takuva, Azwidhwi Takalani, Nigel Garrett, et al.
JAAD International|November 11, 2024
Patients with severe cutaneous adverse drug reactions have extremely high hair cortisol concentrations that do not correlate with the presence of depressionEddy M Zitha, Ogheneochuko U Oputu, Sthomo Mevana, et al.
Plos Pathogens|September 19, 2025
The association of class II HLA alleles with tuberculosis-associated immune reconstitution inflammatory syndromePhuti Choshi, Sarah Pedretti, Tafadzwa Chimbetete, et al.
Plos One|April 25, 2015
High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisElize Pietersen, Jonny Peter, Elizabeth Streicher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis SettingsRose Selim, Bukiwe Thwala, Mireille Porter, et al.
Pageof 11